Disc Medicine, Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 7.
AI score 7 (80% interval 5–8) · evidence grade D · US · Pharma / Chemicals
Stated reason: On February 26, 2026, the board of directors of Disc Medicine, Inc. (the “Company”) approved, and management began implementing, a restructuring plan (the “Restructuring Plan”) to better align the Company’s workforce with its near-term strategic priorities following the receipt of a complete response letter from the U.S. Food and Drug Administration (“FDA”) on February 13, 2026 with respect to the Company’s New Drug …
Why 7: Cost-cutting / efficiency · Drivers: industry AI exposure +0.5, role AI exposure +0.2
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.811, industry exposure 0.712, AI investment 0.0, contrary 0.0 · named roles: Bookkeeping, Accounting, and Auditing Clerks, Computer and Information Systems Managers, General and Operations Managers, Loan Interviewers and Clerks, Office C
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
